| __timestamp | Dr. Reddy's Laboratories Limited | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 132170000000 | 3355384000 |
| Thursday, January 1, 2015 | 148189000000 | 3934563000 |
| Friday, January 1, 2016 | 154708000000 | 4049830000 |
| Sunday, January 1, 2017 | 140809000000 | 4318073000 |
| Monday, January 1, 2018 | 142028000000 | 4486724000 |
| Tuesday, January 1, 2019 | 153851000000 | 5098691000 |
| Wednesday, January 1, 2020 | 174600000000 | 5340038000 |
| Friday, January 1, 2021 | 189722000000 | 4933118000 |
| Saturday, January 1, 2022 | 214391000000 | 6063967000 |
| Sunday, January 1, 2023 | 245879000000 | 6591977000 |
| Monday, January 1, 2024 | 279164000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, Dr. Reddy's Laboratories Limited and Grifols, S.A. stand as titans of industry. Over the past decade, Dr. Reddy's has demonstrated a remarkable growth trajectory, with its revenue surging by over 110% from 2014 to 2023. This Indian multinational has consistently outpaced its Spanish counterpart, Grifols, whose revenue grew by approximately 96% during the same period.
Dr. Reddy's Laboratories, with its robust pipeline and strategic global expansions, has seen its revenue climb from 132 billion to 246 billion, showcasing its dominance in the market. Meanwhile, Grifols, a leader in plasma-derived therapies, has increased its revenue from 3.4 billion to 6.6 billion, reflecting its steady growth.
As we look to the future, the absence of data for 2024 for Grifols leaves room for speculation. Will Grifols close the gap, or will Dr. Reddy's continue its upward trajectory?
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Grifols, S.A.
Alnylam Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited: Examining Key Revenue Metrics
Dr. Reddy's Laboratories Limited vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
Dr. Reddy's Laboratories Limited vs Vericel Corporation: Annual Revenue Growth Compared
Revenue Insights: Dr. Reddy's Laboratories Limited and Merus N.V. Performance Compared
Annual Revenue Comparison: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Who Generates More Revenue? Dr. Reddy's Laboratories Limited or Travere Therapeutics, Inc.
BioMarin Pharmaceutical Inc. and Grifols, S.A.: A Comprehensive Revenue Analysis
Revenue Insights: Walgreens Boots Alliance, Inc. and Grifols, S.A. Performance Compared
Revenue Showdown: Grifols, S.A. vs PTC Therapeutics, Inc.
Revenue Insights: Grifols, S.A. and Arrowhead Pharmaceuticals, Inc. Performance Compared
Grifols, S.A. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?